Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses how AI/ML is disrupting R&D across the board.  

In this episode: 

• How working in synergy with clinicians and research scientists, AI/ML can provide a much-needed augmentation to how drugs are developed.  
• Understand where to apply AI, whether it's early in drug discovery, to find the right patient subpopulations or to do disease modeling.  
• Explore using a machine learning approach based on fairness ranking systems to best represent a clinical trial patient base and address the challenge of diversity and inclusion.